The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of everolimus (E), bevacizumab (B), and docetaxel (D) for castration resistant prostate cancer (CRPC).
 
Mitchell E. Gross
Research Funding - Janssen Oncology; Millennium; Novartis
 
Tanya B. Dorff
Honoraria - Astellas Pharma; Bayer; Dendreon; Medivation; Pfizer; Sanofi
Consulting or Advisory Role - Dendreon
Speakers' Bureau - Bayer; Medivation; Pfizer
Research Funding - Bristol-Myers Squibb
 
David I. Quinn
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva
 
Kristy Massopust
No Relationships to Disclose
 
Patricia M Diaz
No Relationships to Disclose
 
Olga O. Castellanos
No Relationships to Disclose
 
David B. Agus
Consulting or Advisory Role - Life Technologies Corporation
Other Relationship - Applied Proteomics